Results 1 to 10 of about 210,282 (254)

Homologous Recombination [PDF]

, 2005
openaire   +1 more source

Development of a lactate metabolism signature for predicting homologous recombination repair status in breast cancer. [PDF]

Sci Rep
Lin Y, Jiang L, Hu S, Zhang Y, Luo M.
europepmc   +1 more source

Homologous recombination deficiency correlates with tumor-infiltrating lymphocytes and predicts patient outcomes in hormone receptor-positive/HER2-negative breast cancer. [PDF]

Ther Adv Med Oncol
Zhang SJ, Fu JF, Li CC, Wang L, Zhao X, Zhu XY, Qian ZL, Sun WY, Zheng LF, Chen XY, Lu X, Cao WM.   +11 more
europepmc   +1 more source

The Potential of DNA Polymerase Theta (POLQ) Inhibitors as Cancer Therapy for Homologous Recombination (HR)-Deficient Tumors. [PDF]

ACS Med Chem Lett
Abdel-Magid AF.
europepmc   +1 more source

EXPRESSION OF CONCERN: Overexpression of TNKS1BP1 in Lung Cancers and Its Involvement in Homologous Recombination Pathway of DNA Double-Strand Breaks. [PDF]

Cancer Med
europepmc   +1 more source

Prevalence and spectrum of homologous recombination repair mutations in patients with metastatic prostate cancer from India. [PDF]

Oncologist
Baskarane H, Jain R, Divakar MK, Seth A, Nayak B, Bakhshi S, Sahoo RK, Kumar A, Sharma A, Kaushal S, Haresh KP, Hooda V, Vasudeva P, Singh PP, Agarwal R, Vasundhara S, Agarwal N, Batra A.   +17 more
europepmc   +1 more source

Dynamic changes in homologous recombination status before and after chemotherapy in advanced ovarian, fallopian tube, and primary peritoneal cancers. [PDF]

J Ovarian Res
Morimoto A, Matsumoto T, Teramoto N, Murakami S, Usami T, Murai J, Sugiyama T.   +6 more
europepmc   +1 more source

A comprehensive genomic framework for identifying genes predisposing to homologous recombination repair-deficient breast or ovarian cancer. [PDF]

BJC Rep
Camacho-Valenzuela J, Matis T, Roca C, Cuamatzi Flores JL, Hamel N, Rivera B, Gravel S, Polak P, Robles-Espinoza CD, Foulkes WD.   +9 more
europepmc   +1 more source

Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient Cohort. [PDF]

JCO Precis Oncol
Nassief G, Adeyelu T, Elliott A, Phillipps J, Morecroft R, Zhou AY, Szlosarek PW, Robert C, Abdulla F, Vanderwalde A, Park SJ, Chen D, Ansstas G.   +12 more
europepmc   +1 more source

Targeting IP₆ signaling to destabilize homologous recombination proteins to overcome PARP inhibitor resistance. [PDF]

Nat Commun
Lee SG, Seo Y, Jeong S, Chung Y, Kong S, Kim M, Rhlee JH, Um S, Mathew BP, Maiti S, Kuram MR, Abozeid MA, Park A, Yoo JN, Khim KW, Son K, Amarsanaa E, Kim K, Hong S, Choi J, Park IB, Lee EA, Jeon JH, Park JH, Han JS, Park CY, Kim S, Choi JH, Hong SY, Seo MD, Lee H, Lee JY, Myung K.   +32 more
europepmc   +1 more source